Push Health vs Zealthy
Zealthy costs $664 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Zealthy
Best for: coaching bundled into the price rather than sold separately
Visit Zealthy →If you are choosing between Push Health and Zealthy, the first difference is cost: Zealthy is $664 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Push Health leads our six-part score, 5.6 to 5.4. One of the two has an FDA warning letter on record, covered below.
Push Health vs Zealthy price
Zealthy is the cheaper way in: $286 a month against $950 a month at Push Health. That is $664 less each month (70% lower), or about $7,968 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Zealthy ($286 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only Zealthy lists tirzepatide.
On format, Push Health prices brand-name pens, while Zealthy prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.
Where each one treats patients
Push Health does not publish where it ships, and Zealthy lists 34 states.
Pricing
Push Health
Ozempic / brand
Zealthy
$151 medication + $135 monthly membership
$216 medication + $135 monthly membership
What each price covers
Zealthy's price also covers the clinician visit, shipping and coaching, which Push Health does not claim.
Push Health does not say what its price includes.
Zealthy is silent on the medication itself and lab work.
Push Health
Inclusions not disclosed.
Zealthy
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Push Health scores 5.6 and Zealthy 5.4 out of 10.
Push Health is stronger on value (5.3 vs 3.0) and trust & safety (4.0 vs 3.0).
Zealthy is stronger on effectiveness (10.0 vs 9.0), accessibility (7.4 vs 5.0) and support (5.5 vs 5.0).
User experience is within half a point.
Push Health
5.6/10
Zealthy
5.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Zealthy has 2 FDA warning letters on record.
Push Health has no FDA warning letter on record with us.
Features & Coverage
| Feature | Push Health | Zealthy |
|---|---|---|
| Starting Price | $950/mo | ✓$286/mo |
| Features | ✓5 features | 3 features |
| States Available | Not disclosed | 34 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 2 letters |
About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →About Zealthy
Active federal litigation and two FDA warning letters are disclosed in full; the entry exists here only for completeness, and the warnings and cons sections should be read before considering it. Zealthy sells compounded semaglutide and tirzepatide on an asynchronous telehealth model. FitRX, LLC is the legal entity, recently renamed Gronk Inc.
Read our full Zealthy review →Pros & Cons
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Zealthy
What we like
- The monthly price includes clinician visits, shipping and coaching
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Serves only 34 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Zealthy 2 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Push Health wins this one, 5.6 to 5.4, above all for semaglutide from $950/month. Zealthy undercuts it by $664 a month, so if the monthly bill is what decides it, Zealthy is the pick. Zealthy fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Choose Zealthy if…
You want coaching bundled into the price rather than sold separately and an opening price near $286 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Push Health vs Zealthy: FAQ
Close alternatives to Push Health and Zealthy
- Push Health vs JumpstartMD
- Push Health vs Marek Health
- Push Health vs Cost Plus Drugs
- Push Health vs Medi-Weightloss
- Zealthy vs Aspen
- Zealthy vs Joey Med
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.